BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

NABsys, Inc. CEO Barrett Bready Named Rhode Island Innovator of the Year


9/29/2011 11:22:16 AM

PROVIDENCE, R.I., Sept. 29, 2011 /PRNewswire/ -- Dr. Barrett Bready, CEO of NABsys, Inc., has been named Rhode Island's Innovator of the Year. Dr. Bready will be honored at a ceremony tonight at Bryant University. The Rhode Island Innovation Awards, presented by the Providence Business News in partnership with the Rhode Island Economic Development Corporation, and sponsored by Bryant University, Cox Business, Edwards Angell Palmer & Dodge, and Gencorp, are designed to honor Rhode Island-based companies, organizations and individuals that constantly replace existing methods, models and products with better ones.

NABsys' vision is to power DNA sequencing and analysis by using solid-state systems coupled with innovations in chemistry and algorithms to achieve unprecedented levels of accuracy, speed and cost. Moreover, they will reveal long-range DNA sequence information not accessible with current sequencing technologies. These solid-state systems are being designed to address a broad range of applications, from analysis of DNA structural variation, to sequencing of targeted genes, to whole-genome sequencing. The levels of performance being targeted will dramatically impact biological research in many fields, and for the first time provide the information content, accuracy, throughput and cost required for clinical applications of whole-genome sequencing.

About NABsys

NABsys is a life sciences company working at the intersection of physics, biology and computer science to develop its proprietary electronic solid-state DNA sequencing platform. Designed to offer scientists orders of magnitude improvements in accuracy, speed, cost and scalability of genome sequencing, the same platform enables other forms of DNA analysis, such as targeted gene sequencing and characterization of genome structural variation. NABsys was the first company to receive a "$1000 Genome" award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to sequencing. For more information about NABsys, please visit www.NABsys.com.

NOTE: NABsys and the NABsys logo are registered trademarks owned or used by NABsys, Inc.

SOURCE NABsys



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES